These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 31118805)

  • 41. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.
    Hu J; Yang L; Peng X; Mao M; Liu X; Song J; Li H; Chen F
    Hum Cell; 2022 Nov; 35(6):1838-1855. PubMed ID: 36087219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
    Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
    Front Oncol; 2020; 10():718. PubMed ID: 32547941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma.
    Zhang L; Qiao Y; Huang J; Wan D; Zhou L; Lin S; Zheng S
    Front Med (Lausanne); 2020; 7():556. PubMed ID: 33072775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.
    Shen S; Yan J; Zhang Y; Dong Z; Xing J; He Y
    Ann Transl Med; 2021 Jan; 9(1):59. PubMed ID: 33553352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
    Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
    Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis and Validation of circRNA-miRNA Network in Regulating m
    Chi F; Cao Y; Chen Y
    Front Oncol; 2021; 11():560506. PubMed ID: 33708621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic Analyses of the Role of the Reader Protein of
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene Signatures and Prognostic Values of m
    Lu S; Yu Z; Xiao Z; Zhang Y
    Front Oncol; 2020; 10():875. PubMed ID: 32596151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
    Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
    J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
    [No Abstract]   [Full Text] [Related]  

  • 51. Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma.
    Zhu P; Ren Q; He N; Zhou C; Jin Q; Gong Z
    Oncol Lett; 2021 Mar; 21(3):221. PubMed ID: 33613710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database.
    Zhu XL; Li Q; Shen J; Shan L; Zuo ED; Cheng X
    Transl Cancer Res; 2021 Dec; 10(12):5337-5351. PubMed ID: 35116381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.
    Zhu J; Tong H; Sun Y; Li T; Yang G; He W
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
    Luo X; Cao M; Gao F; He X
    Exp Hematol Oncol; 2021 Jun; 10(1):35. PubMed ID: 34088349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
    Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
    Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
    [No Abstract]   [Full Text] [Related]  

  • 56. YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer.
    Li C; Zhang C; Zhang G; Chen B; Li X; Li K; Ren C; Wen L; Liao N
    Cancer Biomark; 2022; 35(2):127-142. PubMed ID: 35342079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
    Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
    BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.
    Tsuchiya K; Yoshimura K; Inoue Y; Iwashita Y; Yamada H; Kawase A; Watanabe T; Tanahashi M; Ogawa H; Funai K; Shinmura K; Suda T; Sugimura H
    Oncoimmunology; 2021; 10(1):1962656. PubMed ID: 34408926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.